Related Experiment Video

Updated: Jun 6, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.5K

miR-5100 Overexpression Inhibits Prostate Cancer Progression by Inducing Cell Cycle Arrest and Targeting E2F7

An Zhang1, Wen Deng2, Haojie Shang2

  • 1Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Current Issues in Molecular Biology
|November 26, 2024
PubMed

Insights

MicroRNA 5100 (miR-5100) acts as a tumor suppressor in prostate cancer (PCa). It inhibits PCa cell growth and spread by targeting E2F7 and blocking cell cycle progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer (PCa) remains a significant cause of cancer-related mortality in men.
  • MicroRNAs (miRNAs) are crucial regulators in cancer development and progression.
  • Innovative therapeutic strategies for PCa are urgently needed.

Purpose of the Study:

  • To investigate the tumor-suppressive function of miR-5100 in prostate cancer.
  • To elucidate the molecular mechanism underlying miR-5100's role in PCa.
  • To identify potential therapeutic targets related to miR-5100.

Main Methods:

  • Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to assess miR-5100 expression.
  • Functional assays (proliferation, migration, invasion) to evaluate miR-5100's impact.
  • RNA-sequencing to identify miR-5100 target genes.
  • Reporter gene assays and RIP assays to confirm direct targeting.
  • Flow cytometry to analyze cell cycle progression.

Main Results:

  • miR-5100 expression was significantly lower in PCa cell lines compared to benign prostate cells.
  • Overexpression of miR-5100 suppressed PCa cell proliferation, migration, and invasion.
  • RNA-sequencing identified numerous candidate target genes involved in cell cycle regulation.
  • E2F7 was confirmed as a direct target of miR-5100.
  • miR-5100 overexpression led to cell cycle arrest at the S phase.
  • E2F7 partially rescued the tumor-suppressive effects of miR-5100.

Conclusions:

  • miR-5100 functions as a tumor suppressor in prostate cancer.
  • miR-5100 exerts its tumor-suppressive effects by inhibiting cell cycle progression.
  • Targeting E2F7 is a key mechanism through which miR-5100 suppresses PCa growth.
Keywords:
E2F7cell cyclemiR-5100microRNAprostate cancer (PCa)

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K